Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Venous Thromboembolism × Other × Clear all

Phase

Status

Sponsor Class

INDUSTRY 2 OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Classical hematology 100 Thoracic 12 Gastrointestinal 12 Plasma cell 8 CNS 8 Myeloid 4 Gynecologic 4 Other hematologic neoplasm 3 Lymphoid 3 Breast 3 Genitourinary 2 Sarcoma 1 Other 1

Conditions

Obesity 333 Neoplasms 123 Breast Neoplasms 88 Mucositis 84 Overweight 81 Sexual Dysfunction, Physiological 77 Polycystic Ovary Syndrome 77 Dyspnea 52 Motor Activity 48 Weight Loss 33 Constipation 31 Prostatic Neoplasms 29 Head and Neck Neoplasms 28 Diabetes Mellitus 28 Colorectal Neoplasms 28 Endometrial Neoplasms 23 Depression 23 Lung Neoplasms 22 Diabetes Mellitus, Type 2 21 Multiple Endocrine Neoplasia Type 1 19 Cardiovascular Diseases 19 Anxiety Disorders 18 Pain 16 Obesity, Morbid 16 Metabolic Syndrome 16 Insulin Resistance 16 Precursor Cell Lymphoblastic Leukemia-Lymphoma 15 Colonic Neoplasms 15 Cancer-related Fatigue 15 Stomatitis 14

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03297359 2024-01-23

WAVe

Ottawa Hospital Research Institute

Phase 2 Terminated

Classical hematologyOther

Neoplasms, Obesity, Venous Thromboembolism

Data powered by HemOnc (CC BY 4.0) Colophon ⚡